Telehealth-delivered exercise to treat incontinence in women following gynaecological cancer

The University of Melbourne0 个研究点目标入组 72 人开始时间: 2022年4月20日最近更新: 2024年8月12日

适应症

试验速览

暂无简介。

•Women aged 18 years or more; following cancer treatment (with or without radiotherapy) for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour; have the ability to speak and read English sufficiently for purposes of the study; have primary cancer treatment completed at least 6 months ago or adjuvant therapy completed at least 3 months ago; have self-reported urinary incontinence (at least 1 episode per week for last 4 weeks); have not received (in clinic or telehealth) >1 physiotherapy-supervised pelvic floor treatment session for urinary incontinence since commencing cancer treatment OR in the previous 4 years (whichever is most recent); and have a home internet connection and a smartphone.

•Women who are pregnant or breastfeeding; have given birth within the last 12 months; have a severe pelvic organ prolapse; have a vaginal pessary ring in situ; have a significant neurological disorder; have a severe physical or psychiatric impairment; unable to participate in the e-health components of the study; have had pelvic surgery for incontinence or pelvic organ prolapse in the last 2 years; are not willing to use an intra-vaginal biofeedback device or videoconferencing software (Zoom or other) or are unable to give informed consent or complete all study and assessment procedures.

发起方